Trump's executive order to expedite reclassifying cannabis means wider access to marijuana and that it could be used like any other prescribed drug during the workday.

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses and patients.

U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here’s a look at what that would mean for people shopping at dispensaries across the country.

Starting next month, Howard County’s first responders will be allowed to use medically prescribed cannabis off-duty, County Executive Calvin Ball announced Friday. The union that represents

Innovative Industrial trades at just 0.74x tangible book and 7.4x AFFO, with a robust 14.3% dividend yield. Read why IIPR stock is a Strong Buy.

As the week comes to a close, a new deal has emerged between President Trump’s Trump Media and Technology Group (DJT), also known as TMTG, and TAE Technologies, a private fusion energy development company. This all-stock transaction, valued at over $6 billion, will result in the world’s first publicly traded fusion company.

A recent review published in JAMA found that the evidence to support the use of cannabis and cannabinoids for most medical indications is insufficient. The authors state that only specific pharmaceutical-grade cannabinoid products approved by the Food and Drug Administration (FDA) have demonstrated clear clinical benefits.

The best cannabis stocks to follow Trump’s Schedule III classification are high-quality names with access to the Canadian market. Click here to see the top stocks.